Cargando…
Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study
OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analys...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546126/ https://www.ncbi.nlm.nih.gov/pubmed/35044676 http://dx.doi.org/10.1002/ijgo.14097 |
_version_ | 1784804972865519616 |
---|---|
author | Verbakel, Jan Yvan Heremans, Ruben Wynants, Laure Epstein, Elisabeth De Cock, Bavo Pascual, Maria Angela Leone, Francesco Paolo Giuseppe Sladkevicius, Povilas Alcazar, Juan Luis Van Pachterbeke, Catherine Jokubkiene, Ligita Fruscio, Robert Bourne, Tom Van Calster, Ben Timmerman, Dirk Van den Bosch, Thierry |
author_facet | Verbakel, Jan Yvan Heremans, Ruben Wynants, Laure Epstein, Elisabeth De Cock, Bavo Pascual, Maria Angela Leone, Francesco Paolo Giuseppe Sladkevicius, Povilas Alcazar, Juan Luis Van Pachterbeke, Catherine Jokubkiene, Ligita Fruscio, Robert Bourne, Tom Van Calster, Ben Timmerman, Dirk Van den Bosch, Thierry |
author_sort | Verbakel, Jan Yvan |
collection | PubMed |
description | OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analyses. Three features—age, body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters), and nulliparity—were defined a priori for baseline risk assessment of endometrial malignancy. The following variables were tested for added value: intrauterine contraceptive device, bleeding pattern, age at menopause, coexisting diabetes/hypertension, physical exercise, fat distribution, bra size, waist circumference, smoking/drinking habits, family history, use of hormonal/anticoagulant therapy, and sonographic endometrial thickness. We calculated adjusted odds ratio, optimism‐corrected area under the receiver operating characteristic curve (AUC), R(2), and Akaike's information criterion. RESULTS: Of 2417 women, 155 (6%) had endometrial malignancy or endometrial intraepithelial neoplasia. In women with endometrial cancer median age was 67 years (interquartile range [IQR] 56–75 years), median parity was 2 (IQR 0–10), and median BMI was 28 (IQR 25–32). Age, BMI, and parity produced an AUC of 0.82. Other variables marginally affected the AUC, adding endometrial thickness substantially increased the AUC in postmenopausal women. CONCLUSION: Age, parity, and BMI help in the assessment of endometrial cancer risk in women with abnormal uterine bleeding. Other patient information adds little, whereas sonographic endometrial thickness substantially improves assessment. |
format | Online Article Text |
id | pubmed-9546126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95461262022-10-14 Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study Verbakel, Jan Yvan Heremans, Ruben Wynants, Laure Epstein, Elisabeth De Cock, Bavo Pascual, Maria Angela Leone, Francesco Paolo Giuseppe Sladkevicius, Povilas Alcazar, Juan Luis Van Pachterbeke, Catherine Jokubkiene, Ligita Fruscio, Robert Bourne, Tom Van Calster, Ben Timmerman, Dirk Van den Bosch, Thierry Int J Gynaecol Obstet Clinical Articles OBJECTIVE: To investigate the association between personal history, anthropometric features and lifestyle characteristics and endometrial malignancy in women with abnormal vaginal bleeding. METHODS: Prospective observational cohort assessed by descriptive and multivariable logistic regression analyses. Three features—age, body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters), and nulliparity—were defined a priori for baseline risk assessment of endometrial malignancy. The following variables were tested for added value: intrauterine contraceptive device, bleeding pattern, age at menopause, coexisting diabetes/hypertension, physical exercise, fat distribution, bra size, waist circumference, smoking/drinking habits, family history, use of hormonal/anticoagulant therapy, and sonographic endometrial thickness. We calculated adjusted odds ratio, optimism‐corrected area under the receiver operating characteristic curve (AUC), R(2), and Akaike's information criterion. RESULTS: Of 2417 women, 155 (6%) had endometrial malignancy or endometrial intraepithelial neoplasia. In women with endometrial cancer median age was 67 years (interquartile range [IQR] 56–75 years), median parity was 2 (IQR 0–10), and median BMI was 28 (IQR 25–32). Age, BMI, and parity produced an AUC of 0.82. Other variables marginally affected the AUC, adding endometrial thickness substantially increased the AUC in postmenopausal women. CONCLUSION: Age, parity, and BMI help in the assessment of endometrial cancer risk in women with abnormal uterine bleeding. Other patient information adds little, whereas sonographic endometrial thickness substantially improves assessment. John Wiley and Sons Inc. 2022-02-07 2022-10 /pmc/articles/PMC9546126/ /pubmed/35044676 http://dx.doi.org/10.1002/ijgo.14097 Text en © 2022 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Clinical Articles Verbakel, Jan Yvan Heremans, Ruben Wynants, Laure Epstein, Elisabeth De Cock, Bavo Pascual, Maria Angela Leone, Francesco Paolo Giuseppe Sladkevicius, Povilas Alcazar, Juan Luis Van Pachterbeke, Catherine Jokubkiene, Ligita Fruscio, Robert Bourne, Tom Van Calster, Ben Timmerman, Dirk Van den Bosch, Thierry Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title | Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title_full | Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title_fullStr | Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title_full_unstemmed | Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title_short | Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study |
title_sort | risk assessment for endometrial cancer in women with abnormal vaginal bleeding: results from the prospective ieta‐1 cohort study |
topic | Clinical Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546126/ https://www.ncbi.nlm.nih.gov/pubmed/35044676 http://dx.doi.org/10.1002/ijgo.14097 |
work_keys_str_mv | AT verbakeljanyvan riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT heremansruben riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT wynantslaure riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT epsteinelisabeth riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT decockbavo riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT pascualmariaangela riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT leonefrancescopaologiuseppe riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT sladkeviciuspovilas riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT alcazarjuanluis riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT vanpachterbekecatherine riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT jokubkieneligita riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT frusciorobert riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT bournetom riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT vancalsterben riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT timmermandirk riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT vandenboschthierry riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy AT riskassessmentforendometrialcancerinwomenwithabnormalvaginalbleedingresultsfromtheprospectiveieta1cohortstudy |